Type 1 angiotensin receptor pharmacology: Signaling beyond G proteins

Drugs that inhibit the production of angiotensin II (AngII) or its access to the type 1 angiotensin receptor (AT(1)R) are prescribed to alleviate high blood pressure and its cardiovascular complications. Accordingly, much research has focused on the molecular pharmacology of AT(1)R activation and si...

Descripción completa

Detalles Bibliográficos
Autores principales: Oro, Cristina, Qian, Hongwei, Thomas, Walter G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2007
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112676/
https://www.ncbi.nlm.nih.gov/pubmed/17125841
http://dx.doi.org/10.1016/j.pharmthera.2006.10.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112676/
https://www.ncbi.nlm.nih.gov/pubmed/17125841
http://dx.doi.org/10.1016/j.pharmthera.2006.10.001

Ejemplares similares